{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:24:10Z","timestamp":1791095050470,"version":"4.1.0"},"reference-count":130,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","plefa.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.plefa.2005.04.008","type":"journal-article","created":{"date-parts":[[2005,6,3]],"date-time":"2005-06-03T07:37:00Z","timestamp":1117784220000},"page":"65-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"title":["The effect of PPAR\u03b3 ligands on the adipose tissue in insulin resistance"],"prefix":"10.1016","volume":"73","author":[{"given":"A.","family":"Hammarstedt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.X.","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Rotter Sopasakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.plefa.2005.04.008_bib1","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/35055575","article-title":"Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver","volume":"409","author":"Abel","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.plefa.2005.04.008_bib2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1172\/JCI7901","article-title":"Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice","volume":"105","author":"Gavrilova","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.plefa.2005.04.008_bib3","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S1056-8727(96)00090-6","article-title":"The global epidemiology of non-insulin-dependent diabetes mellitus and the metabolic syndrome","volume":"11","author":"Zimmet","year":"1997","journal-title":"J. Diabetes Complications"},{"key":"10.1016\/j.plefa.2005.04.008_bib4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1365-201X.2003.01162.x","article-title":"The role of intramuscular lipid in insulin resistance","volume":"178","author":"Hegarty","year":"2003","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.plefa.2005.04.008_bib5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1146\/annurev.nutr.22.010402.102912","article-title":"Muscle triglyceride and insulin resistance","volume":"22","author":"Kelley","year":"2002","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.plefa.2005.04.008_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/dmrr.260","article-title":"The role of increased liver triglyceride content: a culprit of diabetic hyperglycaemia?","volume":"18","author":"Song","year":"2002","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.plefa.2005.04.008_bib7","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1073\/pnas.94.8.4171","article-title":"Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus","volume":"94","author":"Rondinone","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.plefa.2005.04.008_bib8","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2337\/diabetes.52.3.634","article-title":"Enhanced basal activation of mitogen-activated protein kinases in adipocytes from type 2 diabetes: potential role of p38 in the downregulation of GLUT4 expression","volume":"52","author":"Carlson","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.plefa.2005.04.008_bib9","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s001250051501","article-title":"Impaired phosphorylation and insulin-stimulated translocation to the plasma membrane of protein kinase B\/Akt in adipocytes from Type II diabetic subjects","volume":"43","author":"Carvalho","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.plefa.2005.04.008_bib10","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1096\/fsb2fj000435fje","article-title":"Insulin resistance with low cellular IRS-1 expression is also associated with low GLUT4 expression and impaired insulin-stimulated glucose transport","volume":"15","author":"Carvalho","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.plefa.2005.04.008_bib11","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.bbrc.2004.03.152","article-title":"Evidence of impaired adipogenesis in insulin resistance","volume":"317","author":"Yang","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"Suppl 1","key":"10.1016\/j.plefa.2005.04.008_bib12","first-page":"S16","article-title":"Alterations in lipoprotein lipase in insulin resistance","volume":"19","author":"Eckel","year":"1995","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.plefa.2005.04.008_bib13","doi-asserted-by":"crossref","first-page":"1917S","DOI":"10.1093\/jn\/127.9.1917S","article-title":"Potential role of TNFalpha and lipoprotein lipase as candidate genes for obesity","volume":"127","author":"Kern","year":"1997","journal-title":"J. Nutr."},{"key":"10.1016\/j.plefa.2005.04.008_bib14","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/oby.2003.163","article-title":"Reduced expression of FOXC2 and brown adipogenic genes in human subjects with insulin resistance","volume":"11","author":"Yang","year":"2003","journal-title":"Obes. Res."},{"key":"10.1016\/j.plefa.2005.04.008_bib15","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0006-291X(03)00014-7","article-title":"Reduced expression of PGC-1 and insulin-signaling molecules in adipose tissue is associated with insulin resistance","volume":"301","author":"Hammarstedt","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.plefa.2005.04.008_bib16","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1056\/NEJM199810013391403","article-title":"Obesity associated with a mutation in a genetic regulator of adipocyte differentiation","volume":"339","author":"Ristow","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.plefa.2005.04.008_bib17","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S1534-5807(03)00274-0","article-title":"Genetic modulation of PPARgamma phosphorylation regulates insulin sensitivity","volume":"5","author":"Rangwala","year":"2003","journal-title":"Dev. Cell."},{"key":"10.1016\/j.plefa.2005.04.008_bib18","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1101\/gad.8.10.1224","article-title":"mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer","volume":"8","author":"Tontonoz","year":"1994","journal-title":"Genes Dev."},{"key":"10.1016\/j.plefa.2005.04.008_bib19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0303-7207(00)00211-2","article-title":"A PPARgamma mutant serves as a dominant negative inhibitor of PPAR signaling and is localized in the nucleus","volume":"162","author":"Berger","year":"2000","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.plefa.2005.04.008_bib20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/25931","article-title":"Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma","volume":"395","author":"Nolte","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.plefa.2005.04.008_bib21","doi-asserted-by":"crossref","first-page":"8008","DOI":"10.1128\/MCB.20.21.8008-8017.2000","article-title":"Discrete roles for peroxisome proliferator-activated receptor gamma and retinoid X receptor in recruiting nuclear receptor coactivators","volume":"20","author":"Yang","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.plefa.2005.04.008_bib22","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1083\/jcb.200011148","article-title":"Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice","volume":"154","author":"Michalik","year":"2001","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.plefa.2005.04.008_bib23","doi-asserted-by":"crossref","first-page":"16710","DOI":"10.1074\/jbc.273.27.16710","article-title":"Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner","volume":"273","author":"Motojima","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2005.04.008_bib24","doi-asserted-by":"crossref","first-page":"19269","DOI":"10.1074\/jbc.270.33.19269","article-title":"Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter","volume":"270","author":"Schoonjans","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2005.04.008_bib25","doi-asserted-by":"crossref","first-page":"11012","DOI":"10.1073\/pnas.91.23.11012","article-title":"The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression","volume":"91","author":"Gulick","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.plefa.2005.04.008_bib26","doi-asserted-by":"crossref","first-page":"18767","DOI":"10.1016\/S0021-9258(17)32234-2","article-title":"Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids","volume":"269","author":"Rodriguez","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2005.04.008_bib27","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/31701","article-title":"Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators","volume":"393","author":"Staels","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.plefa.2005.04.008_bib28","doi-asserted-by":"crossref","first-page":"18779","DOI":"10.1074\/jbc.272.30.18779","article-title":"The organization, promoter analysis, and expression of the human PPARgamma gene","volume":"272","author":"Fajas","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2005.04.008_bib29","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0092-8674(95)90194-9","article-title":"A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation","volume":"83","author":"Kliewer","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.plefa.2005.04.008_bib30","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1073\/pnas.94.9.4318","article-title":"Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma","volume":"94","author":"Kliewer","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.plefa.2005.04.008_bib31","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/0092-8674(94)90006-X","article-title":"Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor","volume":"79","author":"Tontonoz","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.plefa.2005.04.008_bib32","doi-asserted-by":"crossref","first-page":"10703","DOI":"10.1073\/pnas.0403652101","article-title":"Selective disruption of PPARgamma 2 impairs the development of adipose tissue and insulin sensitivity","volume":"101","author":"Zhang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.plefa.2005.04.008_bib33","doi-asserted-by":"crossref","first-page":"41925","DOI":"10.1074\/jbc.M206950200","article-title":"Genetic analysis of adipogenesis through peroxisome proliferator-activated receptor gamma isoforms","volume":"277","author":"Mueller","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2005.04.008_bib34","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1101\/gad.13.17.2231","article-title":"Activation and centromeric localization of CCAAT\/enhancer-binding proteins during the mitotic clonal expansion of adipocyte differentiation","volume":"13","author":"Tang","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.plefa.2005.04.008_bib35","doi-asserted-by":"crossref","first-page":"12446","DOI":"10.1073\/pnas.220425597","article-title":"Role of C\/EBP homologous protein (CHOP-10) in the programmed activation of CCAAT\/enhancer-binding protein-beta during adipogenesis","volume":"97","author":"Tang","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.plefa.2005.04.008_bib36","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1073\/pnas.95.8.4333","article-title":"ADD1\/SREBP1 activates PPARgamma through the production of endogenous ligand","volume":"95","author":"Kim","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.plefa.2005.04.008_bib37","doi-asserted-by":"crossref","first-page":"10070","DOI":"10.1074\/jbc.M308522200","article-title":"The peroxisome proliferator-activated receptor gamma regulates expression of the perilipin gene in adipocytes","volume":"279","author":"Arimura","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2005.04.008_bib38","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1002\/j.1460-2075.1996.tb00918.x","article-title":"PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene","volume":"15","author":"Schoonjans","year":"1996","journal-title":"Embo. J."},{"key":"10.1016\/j.plefa.2005.04.008_bib39","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.2337\/diabetes.52.7.1655","article-title":"Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors","volume":"52","author":"Iwaki","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.plefa.2005.04.008_bib40","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1128\/MCB.15.1.351","article-title":"PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene","volume":"15","author":"Tontonoz","year":"1995","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.plefa.2005.04.008_bib41","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1056\/NEJM199411033311803","article-title":"Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone","volume":"331","author":"Nolan","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.plefa.2005.04.008_bib42","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1172\/JCI1235","article-title":"Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats","volume":"101","author":"Okuno","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.plefa.2005.04.008_bib43","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.2337\/diabetes.50.8.1863","article-title":"Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance","volume":"50","author":"de Souza","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.plefa.2005.04.008_bib44","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s00125-004-1612-3","article-title":"Improved insulin sensitivity and adipose tissue dysregulation following short-term treatment with pioglitazone in non-diabetic, insulin-resistant subjects","volume":"48","author":"Hammarstedt","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.plefa.2005.04.008_bib45","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1006\/bbrc.1999.1657","article-title":"Regulation of gene expression by activation of the peroxisome proliferator-activated receptor gamma with rosiglitazone (BRL 49653) in human adipocytes","volume":"265","author":"Rieusset","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.plefa.2005.04.008_bib46","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0168-8227(01)00373-4","article-title":"Troglitazone improves GLUT4 expression in adipose tissue in an animal model of obese type 2 diabetes mellitus","volume":"56","author":"Furuta","year":"2002","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.plefa.2005.04.008_bib47","doi-asserted-by":"crossref","first-page":"30614","DOI":"10.1074\/jbc.M304654200","article-title":"Peroxisome proliferator-activated receptor-gamma represses GLUT4 promoter activity in primary adipocytes, and rosiglitazone alleviates this effect","volume":"278","author":"Armoni","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2005.04.008_bib48","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1042\/bj20031207","article-title":"Rosiglitazone, an agonist of peroxisome-proliferator-activated receptor gamma (PPARgamma), decreases inhibitory serine phosphorylation of IRS1 in vitro and in vivo","volume":"377","author":"Jiang","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.plefa.2005.04.008_bib49","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.2337\/diabetes.48.6.1270","article-title":"Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade","volume":"48","author":"Griffin","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.plefa.2005.04.008_bib50","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.2337\/diabetes.51.8.2412","article-title":"Potentiation of insulin signaling in tissues of Zucker obese rats after acute and long-term treatment with PPARgamma agonists","volume":"51","author":"Jiang","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.plefa.2005.04.008_bib51","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1096\/fj.00-0020com","article-title":"Thiazolidinediones (PPARgamma agonists) but not PPARalpha agonists increase IRS-2 gene expression in 3T3-L1 and human adipocytes","volume":"15","author":"Smith","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.plefa.2005.04.008_bib52","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.2337\/diacare.27.7.1660","article-title":"The effect of pioglitazone on peroxisome proliferator-activated receptor-gamma target genes related to lipid storage in vivo","volume":"27","author":"Bogacka","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.plefa.2005.04.008_bib53","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1210\/en.2003-1336","article-title":"Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans","volume":"145","author":"Fain","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.plefa.2005.04.008_bib54","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1172\/JCI20514","article-title":"Obesity-induced inflammatory changes in adipose tissue","volume":"112","author":"Wellen","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.plefa.2005.04.008_bib55","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","article-title":"Obesity is associated with macrophage accumulation in adipose tissue","volume":"112","author":"Weisberg","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.plefa.2005.04.008_bib56","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1172\/JCI200319451","article-title":"Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance","volume":"112","author":"Xu","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.plefa.2005.04.008_bib57","doi-asserted-by":"crossref","first-page":"9850","DOI":"10.1074\/jbc.M210811200","article-title":"Preadipocyte conversion to macrophage. Evidence of plasticity,","volume":"278","author":"Charriere","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2005.04.008_bib58","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/34184","article-title":"PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines","volume":"391","author":"Jiang","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.plefa.2005.04.008_bib59","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/34178","article-title":"The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation","volume":"391","author":"Ricote","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.plefa.2005.04.008_bib60","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1073\/pnas.72.9.3666","article-title":"An endotoxin-induced serum factor that causes necrosis of tumors","volume":"72","author":"Carswell","year":"1975","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.plefa.2005.04.008_bib61","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/316552a0","article-title":"Identity of tumour necrosis factor and the macrophage-secreted factor cachectin","volume":"316","author":"Beutler","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.plefa.2005.04.008_bib62","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.plefa.2005.04.008_bib63","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1172\/JCI117936","article-title":"Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance","volume":"95","author":"Hotamisligil","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.plefa.2005.04.008_bib64","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1172\/JCI117899","article-title":"The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase","volume":"95","author":"Kern","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.plefa.2005.04.008_bib65","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.2337\/diabetes.51.5.1319","article-title":"Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory","volume":"51","author":"Ruan","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.plefa.2005.04.008_bib66","doi-asserted-by":"crossref","first-page":"13580","DOI":"10.1016\/S0021-9258(18)42251-X","article-title":"Transcriptional repression of the C\/EBP-alpha and GLUT4 genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. Regulations is coordinate and independent of protein synthesis","volume":"267","author":"Stephens","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2005.04.008_bib67","doi-asserted-by":"crossref","first-page":"45777","DOI":"10.1074\/jbc.M301977200","article-title":"Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects","volume":"278","author":"Rotter","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2005.04.008_bib68","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1210\/endo.138.7.5242","article-title":"TNF alpha-mediated inhibition and reversal of adipocyte differentiation is accompanied by suppressed expression of PPARgamma without effects on Pref-1 expression","volume":"138","author":"Xing","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.plefa.2005.04.008_bib69","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/39335","article-title":"Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function","volume":"389","author":"Uysal","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.plefa.2005.04.008_bib70","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1210\/endo.139.12.6337","article-title":"Functional analysis of tumor necrosis factor (TNF) receptors in TNF-alpha-mediated insulin resistance in genetic obesity","volume":"139","author":"Uysal","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.plefa.2005.04.008_bib71","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1172\/JCI10934","article-title":"Insulin\/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways","volume":"107","author":"Rui","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.plefa.2005.04.008_bib72","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1074\/jbc.M208359200","article-title":"c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade","volume":"278","author":"Lee","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2005.04.008_bib73","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1172\/JCI119715","article-title":"Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling","volume":"100","author":"Peraldi","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.plefa.2005.04.008_bib74","doi-asserted-by":"crossref","first-page":"28181","DOI":"10.1074\/jbc.M303141200","article-title":"Troglitazone antagonizes tumor necrosis factor-alpha-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-kappaB","volume":"278","author":"Ruan","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2005.04.008_bib75","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1463-1326.2000.00072.x","article-title":"Troglitazone reduces plasma levels of tumour necrosis factor-alpha in obese patients with type 2 diabetes","volume":"2","author":"Katsuki","year":"2000","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.plefa.2005.04.008_bib76","first-page":"1316","article-title":"No increased insulin sensitivity after a single intravenous administration of a recombinant human tumor necrosis factor receptor: Fc fusion protein in obese insulin-resistant patients","volume":"85","author":"Paquot","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.plefa.2005.04.008_bib77","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/1043-4666(90)90067-4","article-title":"Biochemical and biological analysis of human interleukin 6 expressed in rodent and primate cells","volume":"2","author":"Tanner","year":"1990","journal-title":"Cytokine"},{"key":"10.1016\/j.plefa.2005.04.008_bib78","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s005920050147","article-title":"Circulating levels of interleukin-6, its soluble receptor and interleukin-6\/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus","volume":"36","author":"Kado","year":"1999","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.plefa.2005.04.008_bib79","doi-asserted-by":"crossref","first-page":"E745","DOI":"10.1152\/ajpendo.2001.280.5.E745","article-title":"Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance","volume":"280","author":"Kern","year":"2001","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.plefa.2005.04.008_bib80","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0006-291X(03)00090-1","article-title":"Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes","volume":"301","author":"Fasshauer","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.plefa.2005.04.008_bib81","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/oby.2004.51","article-title":"High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator","volume":"12","author":"Sopasakis","year":"2004","journal-title":"Obes. Res."},{"key":"10.1016\/j.plefa.2005.04.008_bib82","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/43206","article-title":"A family of cytokine-inducible inhibitors of signaling","volume":"387","author":"Starr","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.plefa.2005.04.008_bib83","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1128\/MCB.24.12.5434-5446.2004","article-title":"Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms","volume":"24","author":"Ueki","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.plefa.2005.04.008_bib84","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/01.CIR.0000025403.20953.23","article-title":"Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus","volume":"106","author":"Haffner","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.plefa.2005.04.008_bib85","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0006-2952(00)00299-9","article-title":"Down-regulation by troglitazone of hepatic tumor necrosis factor-alpha and interleukin-6 mRNA expression in a murine model of non-insulin-dependent diabetes","volume":"60","author":"Sigrist","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.plefa.2005.04.008_bib86","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.bbrc.2003.10.013","article-title":"Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone","volume":"311","author":"Lagathu","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.plefa.2005.04.008_bib87","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","article-title":"Positional cloning of the mouse obese gene and its human homologue","volume":"372","author":"Zhang","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.plefa.2005.04.008_bib88","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2337\/diabetes.52.2.232","article-title":"Is the energy homeostasis system inherently biased toward weight gain?","volume":"52","author":"Schwartz","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.plefa.2005.04.008_bib89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.1810001","article-title":"Leptin and hyperleptinemia\u2014from friend to foe for cardiovascular function","volume":"181","author":"Ren","year":"2004","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.plefa.2005.04.008_bib90","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/377527a0","article-title":"Transient increase in obese gene expression after food intake or insulin administration","volume":"377","author":"Saladin","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.plefa.2005.04.008_bib91","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2337\/diab.47.2.219","article-title":"Effects of leptin on insulin secretion from isolated rat pancreatic islets","volume":"47","author":"Ookuma","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.plefa.2005.04.008_bib92","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1172\/JCI119865","article-title":"Leptin selectively decreases visceral adiposity and enhances insulin action","volume":"100","author":"Barzilai","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.plefa.2005.04.008_bib93","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S1097-2765(00)80062-3","article-title":"Identification of SOCS-3 as a potential mediator of central leptin resistance","volume":"1","author":"Bjorbaek","year":"1998","journal-title":"Mol. Cell"},{"key":"10.1016\/j.plefa.2005.04.008_bib94","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2337\/diabetes.48.2.287","article-title":"Microinjection of leptin into the ventromedial hypothalamus increases glucose uptake in peripheral tissues in rats","volume":"48","author":"Minokoshi","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.plefa.2005.04.008_bib95","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1210\/endo.140.8.6890","article-title":"Effects of intravenously infused leptin on insulin sensitivity and on the expression of uncoupling proteins in brown adipose tissue","volume":"140","author":"Rouru","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.plefa.2005.04.008_bib96","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2337\/diabetes.53.2.347","article-title":"Leptin impairs insulin signaling in rat adipocytes","volume":"53","author":"Perez","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.plefa.2005.04.008_bib97","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.1073\/pnas.93.12.5793","article-title":"Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes","volume":"93","author":"Kallen","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.plefa.2005.04.008_bib98","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1172\/JCI118860","article-title":"Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma","volume":"98","author":"De Vos","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.plefa.2005.04.008_bib99","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.1074\/jbc.272.8.5283","article-title":"Functional antagonism between CCAAT\/Enhancer binding protein-alpha and peroxisome proliferator-activated receptor-gamma on the leptin promoter","volume":"272","author":"Hollenberg","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2005.04.008_bib100","doi-asserted-by":"crossref","first-page":"10697","DOI":"10.1074\/jbc.271.18.10697","article-title":"AdipoQ is a novel adipose-specific gene dysregulated in obesity","volume":"271","author":"Hu","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2005.04.008_bib101","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1006\/bbrc.1996.0587","article-title":"cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1)","volume":"221","author":"Maeda","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.plefa.2005.04.008_bib102","doi-asserted-by":"crossref","first-page":"26746","DOI":"10.1074\/jbc.270.45.26746","article-title":"A novel serum protein similar to C1q, produced exclusively in adipocytes","volume":"270","author":"Scherer","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2005.04.008_bib103","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/oxfordjournals.jbchem.a021483","article-title":"Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma","volume":"120","author":"Nakano","year":"1996","journal-title":"J. Biochem. (Tokyo)"},{"key":"10.1016\/j.plefa.2005.04.008_bib104","doi-asserted-by":"crossref","first-page":"9073","DOI":"10.1074\/jbc.M207198200","article-title":"Structure-function studies of the adipocyte-secreted hormone Acrp30\/adiponectin. Implications fpr metabolic regulation and bioactivity","volume":"278","author":"Pajvani","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2005.04.008_bib105","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature01705","article-title":"Cloning of adiponectin receptors that mediate antidiabetic metabolic effects","volume":"423","author":"Yamauchi","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.plefa.2005.04.008_bib106","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1530\/eje.0.1480293","article-title":"The role of the novel adipocyte-derived hormone adiponectin in human disease","volume":"148","author":"Diez","year":"2003","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.plefa.2005.04.008_bib107","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1210\/jcem.86.8.7741","article-title":"Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin","volume":"86","author":"Yang","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.plefa.2005.04.008_bib108","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","article-title":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity","volume":"7","author":"Yamauchi","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.plefa.2005.04.008_bib109","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.2337\/diabetes.52.5.1182","article-title":"Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients","volume":"52","author":"Pellme","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.plefa.2005.04.008_bib110","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1096\/fj.02-1132com","article-title":"A novel cellular marker of insulin resistance and early atherosclerosis in humans is related to impaired fat cell differentiation and low adiponectin","volume":"17","author":"Jansson","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.plefa.2005.04.008_bib111","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nm1029","article-title":"Adiponectin acts in the brain to decrease body weight","volume":"10","author":"Qi","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.plefa.2005.04.008_bib112","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0006-291X(03)01518-3","article-title":"Adiponectin gene activation by thiazolidinediones requires PPAR gamma 2, but not C\/EBP alpha-evidence for differential regulation of the aP2 and adiponectin genes","volume":"308","author":"Gustafson","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.plefa.2005.04.008_bib113","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.2337\/diabetes.50.9.2094","article-title":"PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein","volume":"50","author":"Maeda","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.plefa.2005.04.008_bib114","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.2337\/diabetes.51.10.2968","article-title":"The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects","volume":"51","author":"Yu","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.plefa.2005.04.008_bib115","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2337\/diacare.25.2.376","article-title":"Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients","volume":"25","author":"Yang","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.plefa.2005.04.008_bib116","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35053000","article-title":"The hormone resistin links obesity to diabetes","volume":"409","author":"Steppan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.plefa.2005.04.008_bib117","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0014-5793(01)02968-4","article-title":"Inhibition by insulin of resistin gene expression in 3T3-L1 adipocytes","volume":"507","author":"Haugen","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.plefa.2005.04.008_bib118","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1006\/bbrc.2001.5460","article-title":"Differential regulation of adipocytokine mRNAs by rosiglitazone in db\/db mice","volume":"286","author":"Moore","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.plefa.2005.04.008_bib119","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/oby.2003.137","article-title":"Correlation between serum resistin level and adiposity in obese individuals","volume":"11","author":"Azuma","year":"2003","journal-title":"Obes. Res."},{"key":"10.1016\/j.plefa.2005.04.008_bib120","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1126\/science.1092341","article-title":"Regulation of fasted blood glucose by resistin","volume":"303","author":"Banerjee","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.plefa.2005.04.008_bib121","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s00109-003-0428-9","article-title":"Resistin: molecular history and prognosis","volume":"81","author":"Banerjee","year":"2003","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.plefa.2005.04.008_bib122","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/oby.2002.9","article-title":"Resistin\u2014resistant to defining its role","volume":"10","author":"Smith","year":"2002","journal-title":"Obes. Res."},{"key":"10.1016\/j.plefa.2005.04.008_bib123","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.tem.2004.06.005","article-title":"Resistin\/ADSF\/FIZZ3 in obesity and diabetes","volume":"15","author":"Sook Sul","year":"2004","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.plefa.2005.04.008_bib124","doi-asserted-by":"crossref","first-page":"25651","DOI":"10.1074\/jbc.C100189200","article-title":"Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists","volume":"276","author":"Way","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.plefa.2005.04.008_bib125","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1006\/bbrc.2001.6015","article-title":"Decreased resistin expression in mice with different sensitivities to a high-fat diet","volume":"289","author":"Le Lay","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.plefa.2005.04.008_bib126","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/oby.2002.149","article-title":"Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss","volume":"10","author":"Milan","year":"2002","journal-title":"Obes. Res."},{"key":"10.1016\/j.plefa.2005.04.008_bib127","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.2337\/diabetes.50.10.2199","article-title":"Resistin\/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans","volume":"50","author":"Savage","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.plefa.2005.04.008_bib128","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1006\/bbrc.2001.5173","article-title":"Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle","volume":"285.","author":"Nagaev","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.plefa.2005.04.008_bib129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/oby.2002.1","article-title":"Resistin gene expression in human adipocytes is not related to insulin resistance","volume":"10","author":"Janke","year":"2002","journal-title":"Obes. Res."},{"key":"10.1016\/j.plefa.2005.04.008_bib130","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0006-291X(02)02841-3","article-title":"Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators","volume":"300","author":"Patel","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095232780500061X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095232780500061X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:02:12Z","timestamp":1760601732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095232780500061X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":130,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S095232780500061X"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2005.04.008","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of PPAR\u03b3 ligands on the adipose tissue in insulin resistance","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins, Leukotrienes and Essential Fatty Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plefa.2005.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}